Vascular Imaging Market By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Nuclear Imaging, X-ray, Others), By Procedure (Coronary Angiography, Peripheral Angiography, Cerebral Angiography, Pulmonary Angiography, Vena Cava Angiography, Others), By Application (Atherosclerosis, Aneurysms, Deep Vein Thrombosis (DVT), Pulmonary Embolism, Stroke, Carotid Artery Disease, Congenital Vascular Disorders, Vascular Tumors, Varicose Veins, Peripheral Arterial Disease (PAD), By End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers (ASCs), Academic & Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Vascular Imaging Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Increasing prevalence of cardiovascular diseases is driving the demand for effective vascular imaging solutions.

3.2.2. Advancements in imaging technologies, such as 3D and contrast-enhanced imaging, are improving diagnostic accuracy and boosting adoption.

3.2.3. Growing aging population globally is contributing to higher rates of vascular disorders requiring regular imaging.

3.3. Key industry pitfalls & challenges

3.3.1. High cost of advanced vascular imaging equipment limits accessibility in low-income and rural areas.

3.3.2. Shortage of skilled radiologists and technicians may hinder effective use and interpretation of imaging results.

3.3.3. Stringent regulatory approval processes can delay the introduction of new imaging technologies to the market.

3.4. Market Opportunities

3.4.1. Expanding telemedicine and remote diagnostics are creating new use cases for portable vascular imaging devices.

3.4.2. Rising healthcare investments in emerging economies offer growth potential for imaging equipment manufacturers.

3.4.3. Integration of AI and machine learning in vascular imaging is opening doors for faster and more accurate diagnoses.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Vascular Imaging Market, Modality Segment Analysis

4.1. Overview of Dynamics

4.1.1. Market Revenue Share, By Modality, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Magnetic Resonance Imaging (MRI)

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Computed Tomography (CT)

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Ultrasound

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Nuclear Imaging

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. X-ray

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.7. Others

4.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Vascular Imaging Market, Procedure Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Procedure, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Coronary Angiography

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Peripheral Angiography

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Cerebral Angiography

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Pulmonary Angiography

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Vena Cava Angiography

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Others

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Vascular Imaging Market, Application Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Application, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Atherosclerosis

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Aneurysms

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Deep Vein Thrombosis (DVT)

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Pulmonary Embolism

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Stroke

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.7. Carotid Artery Disease

6.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.8. Congenital Vascular Disorders

6.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.9. Vascular Tumors

6.9.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.10. Varicose Veins

6.10.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.11. Peripheral Arterial Disease (PAD)

6.11.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Vascular Imaging Market, End-user Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-user, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Hospitals

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Diagnostic Imaging Centers

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Ambulatory Surgical Centers (ASCs)

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Academic & Research Institutes

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Vascular Imaging Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

8.2.2. North America Market Revenue, By Modality, 2025-2035

8.2.3. North America Market Revenue, By Procedure, 2025-2035

8.2.4. North America Market Revenue, By Application, 2025-2035

8.2.5. North America Market Revenue, By End-user, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Modality, 2025-2035

8.2.6.2. U.S. Market Revenue, By Procedure, 2025-2035

8.2.6.3. U.S. Market Revenue, By Application, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Modality, 2025-2035

8.2.7.2. Canada Market Revenue, By Procedure, 2025-2035

8.2.7.3. Canada Market Revenue, By Application, 2025-2035

8.2.7.4. Canada Market Revenue, By End-user, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

8.3.2. Europe Market Revenue, By Modality, 2025-2035

8.3.3. Europe Market Revenue, By Procedure, 2025-2035

8.3.4. Europe Market Revenue, By Application, 2025-2035

8.3.5. Europe Market Revenue, By End-user, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Modality, 2025-2035

8.3.6.2. Germany Market Revenue, By Procedure, 2025-2035

8.3.6.3. Germany Market Revenue, By Application, 2025-2035

8.3.6.4. Germany Market Revenue, By End-user, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Modality, 2025-2035

8.3.7.2. France Market Revenue, By Procedure, 2025-2035

8.3.7.3. France Market Revenue, By Application, 2025-2035

8.3.7.4. France Market Revenue, By End-user, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Modality, 2025-2035

8.3.8.2. U.K. Market Revenue, By Procedure, 2025-2035

8.3.8.3. U.K. Market Revenue, By Application, 2025-2035

8.3.8.4. U.K. Market Revenue, By End-user, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Modality, 2025-2035

8.3.9.2. Italy Market Revenue, By Procedure, 2025-2035

8.3.9.3. Italy Market Revenue, By Application, 2025-2035

8.3.9.4. Italy Market Revenue, By End-user, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Modality, 2025-2035

8.3.10.2. Spain Market Revenue, By Procedure, 2025-2035

8.3.10.3. Spain Market Revenue, By Application, 2025-2035

8.3.10.4. Spain Market Revenue, By End-user, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Modality, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Procedure, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Application, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By End-user, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

8.4.2. Asia Pacific Market Revenue, By Modality, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Procedure, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Application, 2025-2035

8.4.5. Asia Pacific Market Revenue, By End-user, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Modality, 2025-2035

8.4.6.2. China Market Revenue, By Procedure, 2025-2035

8.4.6.3. China Market Revenue, By Application, 2025-2035

8.4.6.4. China Market Revenue, By End-user, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Modality, 2025-2035

8.4.7.2. Japan Market Revenue, By Procedure, 2025-2035

8.4.7.3. Japan Market Revenue, By Application, 2025-2035

8.4.7.4. Japan Market Revenue, By End-user, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Modality, 2025-2035

8.4.8.2. India Market Revenue, By Procedure, 2025-2035

8.4.8.3. India Market Revenue, By Application, 2025-2035

8.4.8.4. India Market Revenue, By End-user, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Modality, 2025-2035

8.4.9.2. Australia Market Revenue, By Procedure, 2025-2035

8.4.9.3. Australia Market Revenue, By Application, 2025-2035

8.4.9.4. Australia Market Revenue, By End-user, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Modality, 2025-2035

8.4.10.2. South Korea Market Revenue, By Procedure, 2025-2035

8.4.10.3. South Korea Market Revenue, By Application, 2025-2035

8.4.10.4. South Korea Market Revenue, By End-user, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Modality, 2025-2035

8.4.11.2. Singapore Market Revenue, By Procedure, 2025-2035

8.4.11.3. Singapore Market Revenue, By Application, 2025-2035

8.4.11.4. Singapore Market Revenue, By End-user, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Modality, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Procedure, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

8.5.2. Latin America Market Revenue, By Modality, 2025-2035

8.5.3. Latin America Market Revenue, By Procedure, 2025-2035

8.5.4. Latin America Market Revenue, By Application, 2025-2035

8.5.5. Latin America Market Revenue, By End-user, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Modality, 2025-2035

8.5.6.2. Brazil Market Revenue, By Procedure, 2025-2035

8.5.6.3. Brazil Market Revenue, By Application, 2025-2035

8.5.6.4. Brazil Market Revenue, By End-user, 2025-2035

8.5.7. Argentina

8.5.7.1. Argentina Market Revenue, By Modality, 2025-2035

8.5.7.2. Argentina Market Revenue, By Procedure, 2025-2035

8.5.7.3. Argentina Market Revenue, By Application, 2025-2035

8.5.7.4. Argentina Market Revenue, By End-user, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Modality, 2025-2035

8.5.8.2. Mexico Market Revenue, By Procedure, 2025-2035

8.5.8.3. Mexico Market Revenue, By Application, 2025-2035

8.5.8.4. Mexico Market Revenue, By End-user, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Modality, 2025-2035

8.5.9.2. Rest of Latin America Market Revenue, By Procedure, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Application, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By End-user, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

8.6.2. MEA Market Revenue, By Modality, 2025-2035

8.6.3. MEA Market Revenue, By Procedure, 2025-2035

8.6.4. MEA Market Revenue, By Application, 2025-2035

8.6.5. MEA Market Revenue, By End-user, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Modality, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Procedure, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Application, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By End-user, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Modality, 2025-2035

8.6.7.2. South Africa Market Revenue, By Procedure, 2025-2035

8.6.7.3. South Africa Market Revenue, By Application, 2025-2035

8.6.7.4. South Africa Market Revenue, By End-user, 2025-2035

8.6.8. Rest of Middle-East & Africa

8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Modality, 2025-2035

8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Procedure, 2025-2035

8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

8.6.8.4. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

9. Company Profile

9.1. GE HealthCare

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. Siemens Healthineers

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. Koninklijke Philips N.V.

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Canon Medical Systems Corporation

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. Fujifilm Holdings Corporation

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. Shimadzu Corporation

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. Hologic, Inc.

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. Samsung Medison Co., Ltd.

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Hitachi, Ltd.

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. Carestream Health

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. Agfa-Gevaert Group

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. Esaote SpA

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. Ziehm Imaging GmbH

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. Mindray Medical International Limited

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. Analogic Corporation

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis